Blood thinner xarelto tested in joint replacement patients to prevent deadly clots
NCT ID NCT05449327
First seen Apr 25, 2026 · Last updated May 07, 2026 · Updated 3 times
Summary
This study looked at whether the blood thinner Xarelto (rivaroxaban) can safely prevent dangerous blood clots in the legs or lungs after total hip or knee replacement surgery. 150 patients in Taiwan were randomly assigned to receive Xarelto or standard care. The researchers measured how many people developed clots or had complications like bleeding or infection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENOUS THROMBOEMBOLISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ditmanson Medical Foundation Chiayi Christian Hospital
Chiayi City, Taiwan, 60002, Taiwan
Conditions
Explore the condition pages connected to this study.